Lecture Notes

**Lecture Coverage:**
- Receptors as Drug Targets
- Ligand Gated Ion Channels
- G-Protein-Coupled Receptors
- Kinase-Linked Receptors
- Nuclear Receptors

---
#### **Receptors as Drug Targets**
- Activated / Inhibited by drugs to achieve therapeutic effect through modulated cellular responses

|        **Receptor**         |    **Effector**    | **Reaction Time** |
| :-------------------------: | :----------------: | :---------------: |
|  Ligand Gated Ion Channels  |    Ion Channels    |        ms         |
| G-Protein-Coupled Receptors |   Other proteins   |         s         |
|   Kinase-Linked Receptors   |   Protein Kinase   |         m         |
|      Nuclear Receptors      | Gene Transcription |        hrs        |


#### **Ligand Gated Ion Channels**
**Structure of Ligand Gated Ion Channels**
- <abbr Title="Allows ionic ligands to pass through after ligand binding">Ionotropic</abbr> Receptors
- 4-5 Homologous subunits (αβγδ)

**Activation of Ligand Gated Ion Channels**

| **Step** |    **Action**     | **Description**                                        |
| :------: | :---------------: | ------------------------------------------------------ |
|    0     |  Inactive State   | Ion Channel is closed by default                       |
|    1     |  Ligand Binding   | Induces conformational change → Opens ion channels     |
|    2     |    Ionic Flow     | Allows ions to flow through → De- / Hyper-polarization |
|    3     | Cellular Response | e.g. Muscle Contraction / Neurotransmitter Exocytosis  |


#### **G-Protein-Coupled Receptors**
**Structure of G-Protein-Coupled Receptors**
- Metabotropic Receptors
- 7 Transmembrane α-helices domains

**Activation of G-Protein-Coupled Receptors**
- Different downstream signals based on G-Protein type:

| **Step** |        **Action**        | G<sub>s</sub> (Stimulatory) | G<sub>i</sub> (Inhibitory)  | G<sub>q</sub>              |
| :------: | :----------------------: | --------------------------- | --------------------------- | -------------------------- |
|    1     |      Ligand Binding      | /                           | /                           | /                          |
|    2     |      Enzyme Effect       | ↑ Adenylyl Cyclase Activity | ↓ Adenylyl Cyclase Activity | ↑ Phospholipase C Activity |
|    3     | 2nd Messenger Metabolism | ↑ ATP → cAMP                | ↓ ATP → cAMP                | ↑ IP3                      |
|    4     |   Downstream Effectors   | ↑ Protein Kinase A Activity | ↓ Protein Kinase A Activity | ↑ Protein Kinase C         |
|    5     |    Cellular Response     | ↑ Protein Phosphorylation   | ↓ Protein Phosphorylation   | ↑ Protein Phosphorylation  |
**Example of G-Protein-Coupled Receptors**
- β-Adrenergic Receptors (G<sub>s</sub>): Epinephrine drug target


#### **Kinase-Linked Receptors**
**Structure of Kinase-Linked Receptors**
- 2 Domains
	- Extracellular Ligand-Binding Domain
	- Intracellular Kinase Domain

**Activation of Kinase-Linked Receptors**

| **Step** |       **Action**        | **Description**                                                                                                                                                            |
| :------: | :---------------------: | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
|    1     |     Ligand Binding      | To Extracellular Domain                                                                                                                                                    |
|    2     |      Dimerization       | Brings Intracellular Kinase Domains into Proximity                                                                                                                         |
|  <br>3   |   Autophosphorylation   | Kinase Domains phosphorylates tyrosine residues of receptor itself                                                                                                         |
|    ^     |     Phosphorylation     | Kinase Domains also phosphorylates docked downstream proteins                                                                                                              |
|  <br>4   | <br>Signal Transduction | Activation of Various Pathways for Cellular Response:<br>MAPK/ERK: Cell Proliferation & Differentiation<br>PI3K/Akt: Cell Survival & Metabolism<br>Stat: Cytokine Response |
**Example of Kinase-Linked Receptors**
- Insulin Receptor (PI3K-Akt): ↑ <abbr Title="Insulin Receptor Substrates">IRS</abbr> Phosphorylation → ↑ <abbr Title="Glucose Transporter Type 4">GLUT4</abbr> Translocation to Cell Membrane → ↑ Glucose Absorption


#### **Nuclear Receptors**
**Structure of Nuclear Receptors**
- 3 Domains
	- Ligand-Binding Domain
	- DNA-Binding Domain: Binds to regulated DNA sequences
	- Transactivation Domain: Recruits Co-activators / Co-suppressors for regulation
- 2 Classes (I, II)

| Differences     | Class I             | Class II     |
| --------------- | ------------------- | ------------ |
| Location        | Cytoplasm → Nucleus | Nucleus      |
| Functional Unit | Homodimers          | Heterodimers |
| Ligand          | Endocrine           | Lipid        |


**Activation of Nuclear Receptors**

| **Step** |     **Action**      | Class I                               | Class II                                    |
| :------: | :-----------------: | ------------------------------------- | ------------------------------------------- |
|    1     |   Ligand Binding    | -                                     | -                                           |
|    2     |    Dissociation     | Dissociation of Receptors From HSPs   | Dissociation of Co-repressors from Receptor |
|   2.5    |    Translocation    | Move to Nucleus                       | No Translocation                            |
|    3     | Protein Recruitment | Recruit Co-activators & Co-repressors | Recruit Co-activators                       |
|    4     |   Gene Regulation   |                                       |                                             |
